ePrints

Blood-borne biomarkers of osteosarcoma: A systematic review

Lookup NU author(s): Dr Kenneth RankinORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

© 2018 Wiley Periodicals, Inc. Osteosarcoma is the most common type of primary malignant bone tumor in children and young adults. Development of clinically useful biomarkers has the potential to improve treatments. The aim of this review was to investigate the recent literature assessing the utility of biomarkers for osteosarcoma. A detailed literature search was performed, with hand searches for related research publications. The search was limited to publications in English between January 2007 and February 2017. Of 286 studies identified, 24 met the inclusion criteria. There is a wide range of osteosarcoma biomarkers identified which act as clinical prognostic factors in patient outcome.

Publication metadata

Author(s): Tan GJS, Gerrand CH, Rankin KS

Publication type: Article

Publication status: Published

Journal: Pediatric Blood and Cancer

Year: 2018

Volume: 66

Issue: 1

Print publication date: 01/01/2019

Online publication date: 24/09/2018

Acceptance date: 30/08/2018

ISSN (print): 1545-5009

ISSN (electronic): 1545-5017

Publisher: John Wiley and Sons Inc.

URL: https://doi.org/10.1002/pbc.27462

DOI: 10.1002/pbc.27462

Altmetrics

Share